Ubang, Judith D.
HRN: 14-82-81 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2022
CO-AMOXICLAV 625MG (TAB)
05/11/2022
05/17/2022
PO
625mg
BID
Severe Anemia
Waiting Final Action